相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Short term 4℃; Long term -20℃.
- 保质期:
见COA
- 英文名:
Recombinant Human LILRB4/CD85k/ILT3, Avi-His-tag
- 库存:
大量
- 供应商:
北京辰辉创聚生物技术有限公司
- 规格:
100ug;1mg;Bulk

| 产品信息
品名:NebuSelect™ Recombinant Human LILRB4/CD85k/ILT3, Avi-His-tag
货号:NBL-242340
品牌:Nebulabio
规格:100ug;1mg;Bulk
| 产品描述
NebuSelect™ Recombinant Human LILRB4/CD85k/ILT3, Avi-His-tag(Cat#NBL-242340) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln22-His257.
| 产品属性
表达系统:HEK293
标签:Avi-His-tag
靶点名称:LILRB4/CD85k/ILT3
物种:Human
分子量:The protein has a predicted MW of 28.6 kDa. Due to glycosylation, the protein migrates to 38-42 kDa based on Bis-Tris PAGE result.
氨基酸序列:
Accession: AAH26309
纯度:>95%
内毒素:<1EU/ug(LAL Method)
储存运输条件: Short term 4℃; Long term -20℃.
| 靶点信息
LILRB4,also known as CD85k and LIR-5, ILT-3,- is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT-3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles.
For Research Use Only!
To get more information, please contact us freely.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验15 August 2011. ^ a b Wheeler, B.; Heimberg, A.; Moy, V.; Sperling, E.; Holstein, T.; Heber, S.; Peterson, K. (2009). "The deep evolution of metazoan microRNAs". Evolution & development 11 (1): 50–68. doi:10.1111/j.1525-142X.2008.00302.x. PMID
,2F12;CRIS-3 Leu LFA-1(gp180/95)的α链 与ICAM-1(CD54)和ICAM-2(CD102)结合 CD11b Mol,OKM1; (Mac-1,CR3,integrin αm G,M,NK gp165/95的α链 C3bi和FB受体,与ICAM-1结合,粘附,调理吞噬 CD11c LeuM5;(CR4,integrin αx) M,G,NK,Tsub gp150/95的α链 C3bi受体,调理吞噬
Scanning the human genome with combinatorial transcription factor libraries Published online: 18 February 2003, doi:10.1038/nbt794 March 2003 Volume 21 Number 3 pp 269 - 274 Pilar Blancafort, Laurent Magnenat & Carlos F
技术资料暂无技术资料 索取技术资料







